EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated Mycoplasma genitalium molecular macrolide resistance detection and nucleic acid target semi-quantitation: patient demographic considerations

Josephine Moore, Trinity Krueger, Amanda Zapp, Stephen C Lavey, Kimber L Munson, Irene A Stafford, Michael E Newcomb, Brian Mustanski, Erik Munson iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00738-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Josephine Moore und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, Marquette University, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Macrolides, Mycoplasma Infections, Drug Resistance, Bacterial. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent work has optimized parameters of a real-time reverse transcriptase PCR-based laboratory-developed test on the Panther Fusion system which detects Mycoplasma genitalium-specific macrolide resistance-associated mutations LDT (MRM-LDT) from primary swab and urine specimens. In this study, MRM-LDT was applied to a large multi-demographic study set to further characterize M. genitalium resistance in the United States. A total of 2,145 primary clinical specimens testing positive for M. genitalium 16S rRNA by transcription-mediated amplification (TMA) were initially titered by the same assay using serial 10-fold dilutions to determine relative target nucleic acid burden. Specimens were then processed for MRM-LDT. Findings were stratified by men who have sex with men (MSM; n = 3 settings), community care ( n = 2), and university student ( n = 3) populations. The mean log 10 target nucleic acid titer of a TMA-positive specimen was 3.46 (median 3; range 0–10). A 43.2% MRM-LDT detection rate was found in specimens derived from community care settings. Analogous assessments of university student and MSM demographics revealed 60.8% and 62.0% detection, respectively ( P ≤ 0.0004 versus community care). Within the university student demographic, differences existed in target nucleic acid titer for two settings ( P = 0.01); similar differences were encountered between a local MSM cohort and two that were nationally based ( P ≤ 0.01). Within the university cohort, MRM-LDT detection rate was increased in symptomatic patients ( P = 0.005). M. genitalium macrolide resistance rates among multiple demographics, as determined by MRM-LDT, are high in the United States and are consistent with target nucleic acid burden within the primary specimen. However, caveats experienced within subgroupings of these demographics support reflex MRM-LDT on M. genitalium -positive specimens. IMPORTANCE Data generated from a high-throughput, automated system and presented in this report expand upon knowledge of Mycoplasma genitalium -specific macrolide resistance in the United States and may further inform providers on population- or demographic-based considerations for macrolide resistance mutation determination in M. genitalium .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumMacrolidesMycoplasma InfectionsDrug Resistance, BacterialAnti-Bacterial AgentsHumansMaleFemaleRNA, Ribosomal, 16SAdultUnited StatesMiddle AgedYoung AdultMutation

Stichwörter der Autor:innen

Mycoplasmoides genitaliummacrolide resistancesemi-quantitationtranscription-mediated amplification

Substanzen

MacrolidesAnti-Bacterial AgentsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, Marquette University, Milwaukee, Wisconsin, USA.
  • Loyola University Parkinson School of Health Sciences and Public Health, Maywood, Illinois, USA.
  • Department of Obstetrics and Gynecology, McGovern Medical School at UTHealth, Houston, Texas, USA.
  • Division of Maternal Fetal Medicine, McGovern Medical School at UTHealth, Houston, Texas, USA.
  • Division of Infectious Diseases, Northwestern University, Chicago, Illinois, USA.
  • Department of Medicine, Northwestern University, Evanston, Illinois, USA.

ORCID-Profile: Erik Munson

Zitieren

APA

Moore, J., Krueger, T., Zapp, A., Lavey, S. C., Munson, K. L., Stafford, I. A., Newcomb, M. E., Mustanski, B., & Munson, E. (2025). Automated Mycoplasma genitalium molecular macrolide resistance detection and nucleic acid target semi-quantitation: patient demographic considerations. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00738-25

Vancouver

Moore J, Krueger T, Zapp A, Lavey SC, Munson KL, Stafford IA, et al. Automated Mycoplasma genitalium molecular macrolide resistance detection and nucleic acid target semi-quantitation: patient demographic considerations. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00738-25

BibTeX
@article{Moore2025,
  author = {Moore, Josephine and Krueger, Trinity and Zapp, Amanda and Lavey, Stephen C and Munson, Kimber L and Stafford, Irene A and Newcomb, Michael E and Mustanski, Brian and Munson, Erik},
  title = {Automated Mycoplasma genitalium molecular macrolide resistance detection and nucleic acid target semi-quantitation: patient demographic considerations},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00738-25}
}
Kostenlos starten →